What happened
On 3 July 2026, the European Securities and Markets Authority (ESMA) issued a statement reminding firms of their obligation to assess whether newly offered products fall within the scope of the existing product intervention measures on binary options. ESMA framed the reminder as a direct response to the growing popularity of prediction markets — also called event contracts — and rising retail participation globally.
According to ESMA, event contracts are products whose financial outcome is binary: a fixed payout or no payout at all, depending on a yes-or-no answer to a question about a future event. These products exist across a wide range of event questions, from sports and politics to economic and market outcomes — many of which now surface on crypto and blockchain-based platforms.
What it means in practice
The core message is one of classification, not new rulemaking. ESMA is not creating fresh obligations; it is clarifying how existing measures already apply. Three points stand out:
- Whether an event contract is a financial instrument depends on the event question. The same commercial format can land in very different regulatory buckets depending on what the contract references.
- Event contracts may also qualify as bets under national gambling legislation. That means firms could face gambling-law exposure in addition to — or instead of — financial-services rules, depending on national interpretation.
- Where an event contract is a financial instrument, it classifies as a derivative. Because the outcome is binary, it falls within the scope of the national product intervention measures on binary options adopted by national competent authorities, which prohibit their marketing, distribution or sale to retail clients.
ESMA also reminded firms that distributing event contracts that qualify as financial instruments in the EU requires authorisation as an investment firm — even where distribution is limited to non-retail clients.
Implications for licensees and applicants
For operators building or launching prediction-market functionality — including crypto-native platforms — this statement narrows the room for regulatory arbitrage. If your product references an event that makes the contract a financial instrument, offering it to retail clients in the EU is prohibited under the binary options measures, and offering it to professional clients still requires an investment-firm authorisation.
A few practical consequences follow:
- A crypto or VASP registration does not cover this activity. Being registered as a crypto-asset service provider is not the same as holding a MiFID II investment-firm authorisation. Where event contracts are derivatives, the investment-services regime applies on top of, or instead of, any crypto authorisation.
- Product design is now a compliance decision. The event question you choose determines whether you fall into financial-instrument territory, gambling territory, or outside both — each with different licensing consequences.
- Cross-border marketing carries elevated risk. Because the binary-options measures were adopted at national level, and gambling law is national, offering the same product across the EU can trigger overlapping and inconsistent obligations.
Concrete next steps to consider
- Inventory your products. Map every event contract or prediction-market instrument against the financial-instrument test and against national gambling definitions before you distribute.
- Confirm your authorisation perimeter. If any product qualifies as a financial instrument, verify whether you hold — or need — an investment-firm authorisation, and remember that this applies even for non-retail distribution.
- Enforce the retail prohibition. Where products are in scope, ensure marketing, distribution and sale to retail clients are technically and contractually blocked, not merely discouraged.
- Plan your regulatory stack. Firms combining crypto services with derivative-like products should structure their authorisations deliberately. If you are assessing your EU footprint or considering a crypto / VASP license in the European Union, evaluate in parallel whether investment-firm authorisation is also required.
ESMA’s statement follows a similar reminder issued earlier in 2026 on CFD product intervention measures amid rising offerings of perpetual futures — signalling a consistent supervisory posture: novel product wrappers do not escape existing rules where their economic substance matches a regulated instrument. Firms should treat classification analysis as a standing obligation, not a one-off exercise.
